AR036718A1 - AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION - Google Patents

AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION

Info

Publication number
AR036718A1
AR036718A1 ARP020103717A ARP020103717A AR036718A1 AR 036718 A1 AR036718 A1 AR 036718A1 AR P020103717 A ARP020103717 A AR P020103717A AR P020103717 A ARP020103717 A AR P020103717A AR 036718 A1 AR036718 A1 AR 036718A1
Authority
AR
Argentina
Prior art keywords
inhibit
production
exoprotein production
effective amount
exoprotein
Prior art date
Application number
ARP020103717A
Other languages
Spanish (es)
Inventor
Worldwide Inc Kimberly-Clark
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,198 external-priority patent/US6596290B2/en
Priority claimed from US09/969,199 external-priority patent/US8084046B2/en
Priority claimed from US09/968,769 external-priority patent/US6534548B1/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of AR036718A1 publication Critical patent/AR036718A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Están descriptos los artículos absorbentes tales como los tapones catameniales. Los artículos absorbentes incluyen una cantidad efectiva de un compuesto inhibidor de isoprenoide para inhibir esencialmente la producción de exotoxinas por bacterias grampositivas. Los compuestos inhibidores de isoprenoide de la presente invención incluyen terpenos y terpenoides los cuales esencialmente reducen la producción de exotoxinas por las bacterias grampositivas.Absorbent articles such as catamenial caps are described. Absorbent articles include an effective amount of an isoprenoid inhibitor compound to essentially inhibit the production of exotoxins by gram-positive bacteria. The isoprenoid inhibitor compounds of the present invention include terpenes and terpenoids which essentially reduce the production of exotoxins by gram-positive bacteria.

ARP020103717A 2001-10-02 2002-10-02 AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION AR036718A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/969,198 US6596290B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions
US09/969,199 US8084046B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using isoprenoids
US09/968,769 US6534548B1 (en) 2001-10-02 2001-10-02 Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria

Publications (1)

Publication Number Publication Date
AR036718A1 true AR036718A1 (en) 2004-09-29

Family

ID=27420758

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103717A AR036718A1 (en) 2001-10-02 2002-10-02 AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION

Country Status (8)

Country Link
EP (1) EP1432458A1 (en)
JP (1) JP2005528928A (en)
KR (1) KR20040044949A (en)
AR (1) AR036718A1 (en)
BR (1) BR0212675A (en)
CA (1) CA2461197A1 (en)
MX (1) MXPA04002473A (en)
WO (1) WO2003028777A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224034A1 (en) * 2002-05-31 2003-12-04 Koenig David W. Personal care article and method for inhibiting attachment of yeast to skin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012695A1 (en) * 1991-01-17 1992-08-06 Water-Jel Technologies, Inc. Burn dressing with tea tree oil
DE69629961T2 (en) * 1995-06-07 2004-07-22 Kimberly-Clark Worldwide, Inc., Neenah Inhibition of exoproteins in absorbent products
DE29521478U1 (en) * 1995-12-05 1997-07-10 Turetschek-Fenke, Adelheid, 80995 München Ergonomic sanitary napkin with high absorbency, antibacterial effect and strong odor control
FR2747310B1 (en) * 1996-04-15 1998-06-05 Inbrand France IMPROVED HYGIENIC PROTECTION COMPRISING AN ANTISEPTIC
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
CN1303305A (en) * 1998-05-29 2001-07-11 金伯利-克拉克环球有限公司 Enhanced odor absorption by natural and synthetic polymers

Also Published As

Publication number Publication date
JP2005528928A (en) 2005-09-29
KR20040044949A (en) 2004-05-31
EP1432458A1 (en) 2004-06-30
CA2461197A1 (en) 2003-04-10
WO2003028777A1 (en) 2003-04-10
BR0212675A (en) 2005-04-12
MXPA04002473A (en) 2004-05-31

Similar Documents

Publication Publication Date Title
CO2021016594A2 (en) Condensed tricyclic pyrroles as modulators of alpha-1 antitrypsin
HN2010002119A (en) 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS
HN1999000106A (en) HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS.
BRPI0810064B8 (en) compounds containing tricyclic nitrogen as antibacterial agents, pharmaceutical compositions comprising said compounds and their use for the treatment of bacterial infections in mammals
CO2021015624A2 (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof and methods of treatment with said compounds
DOP2006000268A (en) ANTIBACTERIAL AGENTS
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
UY27882A1 (en) CHEMICAL COMPOUNDS
ECSP099620A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
UY29613A1 (en) CHEMICAL COMPOUNDS VI
CO2019002246A2 (en) Bicyclic Nitrogenous Heterocyclic Compound
UY27894A1 (en) CINAMIDE DERIVATIVES
UY28695A1 (en) DERIVATIVES OF DIFENILAZETIDONA
ECSP066822A (en) MACRÓLIDOS AND METHODS TO PRODUCE THE SAME
UY36651A (en) ANTIESTROGENIC COMPOUNDS
CO2019011547A2 (en) Novel solid crystalline compound of 3-phenyl-4-propyl-1- (pyridin-2-yl) -1h-pyrazol-5-ol hydrochloride
ECSP099315A (en) KINASE INHIBITORS
NZ716154A (en) Tricyclic benzoxaborole compound, preparation method therefor, and use thereof
MX2019008453A (en) Zwitterionic imidazolinium surfactant and use in the manufacture of absorbent paper.
BR112015026193B8 (en) PHARMACEUTICAL COMPOSITION, METHOD FOR FORMULATING A PHARMACEUTICAL COMPOSITION, USE OF THE PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING BIOFILM FORMATION ON A SURFACE, AND, MANUFACTURED ARTICLE FOR DRESSING
PA8597501A1 (en) AZABICICLIC DERIVATIVES OF PIRIDILOXIMETILO AND BENCISOXAZOL
CL2011000722A1 (en) Pharmaceutical composition in the form of storage stable ointment, comprising: a) a vitamin d compound, b) a corticosteroid and c) a substituted alkylamino compound, in a petrolatum vehicle that optionally contains mineral oil, tocopherol or a combination thereof; use in treatment of psoriasis.
TW200504199A (en) Method of preventing lipids constituting lipid membrane from degradation and use thereof
AR064152A1 (en) ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD.
BRPI0608371B8 (en) herbicidal composition, herbicidal agent and method for controlling undesirable vegetation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal